Network Info

News

The presentation “Health Economic Issues in Leukemia” held on the ELN Symposium in February 2010 by Bengt Jönsson, Stockholm School of Economics is available online.

Event on Life Quality

ELIC organized a very viable, intersectional meeting, addressing all workpackages and nations. More than 100 attendees discussed ongoing projects. The meeting gave a background on activities in the field of quality of life and also late effects and has given a frame for new collaboration in the ELN.

European Clinical Trials Directive

The “Road Map Initiative” is a collaboration of research organisations including the European Leukemia Net which has the aim to contribute to a modification of the European Clinical Trials Directive. It is very important to particularly strengthen the position of investigator-initiated trials in this group. Several workshops on different relevant topics took place so far.

Amendment of CT-Directive

ELN was challenged in a contribution of the amendment of the CT-directive. The commented version of the CT-directive impact assessment is available online.

Updated CML Pocket Card 2010

The updated CML Pocketcard for 2010 is now available online.

Registry of CML patients in failure after Imatinib

Although imatinib is now the first line therapy for chronic myelogenous leukemia patients, experimental and clinical studies suggest that imatinib as a single drug might not be sufficient to eradicate Ph-positive stem cells.

EUTOS: Abstracts and ppt-slides of CML meetings available

A new section of the EUTOS website has been arranged to offer information about actual and forthcoming meetings.

Events

Th 2010/03/11 - Fr 2010/03/12
4th CENTRAL EUROPEAN COURSE (CEC 2010) METHODOLOGY OF CLINICAL TRIALS IN ONCOLOGY
Clinical studies are an important part in the drug development process and in exploring new therapeutic treatment modalities. In···

Th 2010/06/10 - Su 2010/06/13
EHA 2010: 15th Congress of the EHA

Th 2010/09/02 - Su 2010/09/05
The 1st World Congress on Controversies in Hematology (COHEM)
The 1st World Congress on Controversies in Hematology (COHEM) will function as an exclusive forum for international experts···

Tu 2011/02/01 - Th 2011/02/03
8th Annual Symposium of the "European LeukemiaNet" / 12th Annual Symposium of the German Competence Network "Acute and chronic Leukemias"

The European Leukemia Net

161 Participating Centers in 32 Countries (900 Researchers and Associates) are cooperating in the European Leukemia Net. Therein 584 associated scientists from 22 countries are cooperating in the European Leukemia Network. The objective is to integrate the 104 leading leukemia trial groups ( CML, AML, ALL, CLL, MDS, CMPD), their 104 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care (data updated end 2008).

leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה,

The European LeukemiaNet is an EU-funded organisation of physicians, scientists and patients with interest in leukemia. It aims to improve the treatment and knowledge about Leukemia in Europe and spread excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. The European LeukemiaNet is funded by the 6th Framework Program of the European Community.